Amylyx Pharmaceuticals Inc. (NASDAQ: AMLX) is one of the best biotech stocks to invest in now. On June 3, Amylyx Pharmaceuticals announced that the US FDA granted Fast Track designation to AMX0114.

2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts By Adria Cimino – Jun 21, 2025 at 6:10PM ...

Our Methodology To make the list of 10 Biotech Stocks Screaming a Buy, we scanned the US equity markets, focusing on Biotech stocks outperforming the market.

The Massachusetts biotech industry produces an astonishing 15 percent of the entire US drug development pipeline and employs nearly 117,000 people in high-skilled jobs.

The annual Biotechnology Innovation Organization trade show is expected to bring about 20,000 participants to Boston starting on Monday. Here are the expected key topics of discussion.

A dual-track approach has gained momentum for biotech companies as capital markets remain volatile and acquirers become more selective.

Catch up on the latest biotech industry partnerships, publications and personnel appointments with this edition of the biotech bi-weekly. Here, we highlight collaborations that are advancing disease ...

Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other industries as biotechnology has delivered only subpar investor returns.

Biotech company Regeneron to buy bankrupt 23andMe for $256M Regeneron will use trove of 23andMe genetic data to develop medical advances.

Some biotech executives spoke about early-stage testing on condition of anonymity to avoid drawing attention to their companies or risking retribution for criticising the Trump administration.

Over the decades, Kendall Square has become a hub of biotech innovation and a popular location for up and coming life sciences firms. Now, a Harvard-backed Allston is entering the Cambridge ...